| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 58.4903 | 63 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.8965 | 56 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.0042 | 51 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.069 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 68.0749 | 68 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.3248 | 60 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 64.0368 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 60.9042 | 65 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.0653 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 55.417 | 60 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.4215 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 63.6865 | 67 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 61.2264 | 65 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 59.5948 | 64 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 59.9844 | 64 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 58.6605 | 63 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 60.2931 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.9775 | 63 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 60.3234 | 65 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 54.3346 | 58 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 58.2498 | 63 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 61.2545 | 65 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 63.2066 | 66 |